Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide REF: 3D-INA99400CAS: 333994-00-6 | Min. 95% | A consultar | Qui 16 Jan 25 | |
TAK-220 REF: TM-T16973CAS: 333994-00-6 | 98% | A consultar | Qui 23 Jan 25 |
1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide
CAS:333994-00-6
Please enquire for more information about 1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide including the price, delivery time and more detailed …
Fórmula:
C31H41ClN4O3
Pureza:
Min. 95%
Peso molecular:
553.14 g/mol
Ref: 3D-INA99400
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 16 de Janeiro de 2025
TAK-220
CAS:333994-00-6
TAK-220: Oral CCR5 antagonist. IC50: 3.5 nM (RANTES), 1.4 nM (MIP-1α).
Fórmula:
C31H41ClN4O3
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
553.14
Ref: TM-T16973
5mg | 325,00 € | ||
25mg | 1.058,00 € | ||
50mg | 1.384,00 € | ||
100mg | 1.849,00 € | ||
1mL*10mM (DMSO) | 361,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Janeiro de 2025